Molecular Partners AG reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was CHF 0.415 million compared to CHF 11.76 million a year ago. Net loss was CHF 15.99 million compared to CHF 4.52 million a year ago. Basic loss per share from continuing operations was CHF 0.49 compared to CHF 0.14 a year ago. Diluted loss per share from continuing operations was CHF 0.49 compared to CHF 0.14 a year ago.
For the six months, revenue was CHF 3.47 million compared to CHF 184.54 million a year ago. Net loss was CHF 30.77 million compared to net income of CHF 148.61 million a year ago. Basic loss per share from continuing operations was CHF 0.94 compared to basic earnings per share from continuing operations of CHF 4.59 a year ago. Diluted loss per share from continuing operations was CHF 0.94 compared to diluted earnings per share from continuing operations of CHF 4.48 a year ago.